First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset
- Type
- Retraction
- Notice date
- 8/10/2021 0:00
- Journal
- Cancer Science
- Publisher
- Wiley
- Notice DOI
- 10.1111/cas.15066
- Original paper DOI
- 10.1111/cas.14647